GlassScriptPhysician profile
Sydney L Tyson
NPI 1639113665
$31,280.32
in general payments reported to CMS, 2019-2025
37 companies · $1,880 in 2025
The $1,880 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $8,254 · 2020: $3,171 · 2021: $1,308 · 2022: $8,596 · 2023: $3,977 · 2024: $4,095 · 2025: $1,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,200 · Food and Beverage: $4,116 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200 · Travel and Lodging: $423 · Gift: $12.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,200.00 |
| Food and Beverage | $4,115.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
| Travel and Lodging | $423.16 |
| Gift | $12.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $9,532.93 | 2019-2025 | Artevo 800, Veracity Surgical, Atlas 500 |
| Ocular Therapeutix, INC. | $8,205.91 | 2019-2021 | |
| Beaver-Visitec International, INC. | $6,377.94 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $1,126.46 | 2023-2025 | Envista Mx60 Iol, Stellaris, Xiidra |
| Carl Zeiss Meditec USA, INC. | $790.14 | 2021-2025 | Veracity Surgical |
| Biotissue Holdings INC. | $678.60 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $651.54 | 2019-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $507.09 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Alcon Vision LLC | $425.18 | 2019-2025 | Clareon, Hydrus Microstent, Centurion |
| New World Medical,INC. | $402.51 | 2019-2025 | |
| Rxsight INC | $361.13 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Regeneron Healthcare Solutions, INC. | $271.45 | 2022-2025 | Eylea Hd, Eylea |
| Allergan, INC. | $239.46 | 2019-2022 | |
| Glaukos Corporation | $184.80 | 2019-2025 | Idosetr, Idose |
| Ivantis, INC | $162.30 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $147.67 | 2023-2024 | |
| Eyevance Pharmaceuticals LLC | $134.01 | 2021 | |
| Astellas Pharma US INC | $128.00 | 2025 | Izervay |
| Abbvie INC. | $114.69 | 2025 | |
| Apellis Pharmaceuticals, INC. | $113.96 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $109.81 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $96.26 | 2022-2025 | Tyrvaya |
| Sight Sciences, INC. | $94.99 | 2020-2023 | Tearcare System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.04 | 2019 | |
| Carl Zeiss Meditec Production LLC | $69.03 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.21 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $43.36 | 2019-2021 | |
| Sandoz INC. | $36.05 | 2024 | Cimerli |
| Horizon Therapeutics Plc | $27.55 | 2022-2023 | Tepezza |
| Rayner Intraocular Lenses Limited | $21.54 | 2025 | Omidria |
| Johnson & Johnson Vision Care, INC. | $21.11 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Dompe US, INC. | $15.52 | 2022 | |
| Omeros Corporation | $15.26 | 2019 | |
| Eyepoint US, INC. | $14.87 | 2019 | |
| Shire North American Group INC | $13.55 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$74,070.24 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Tyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.